play_arrow
Welcome to Online Radio
The Leading Lifestyle Internet Radio
play_arrow
Music 24/7 - Africana
Online Radio
play_arrow
Music 24/7 - International
Online Radio
play_arrow
Music 24/7 - Gospel
Online Radio
play_arrow
Music 24/7 - Latin America
Online Radio
play_arrow
Talk Shows - Stay Updated
Online Radio
play_arrow
Pillars and Plants - Gospel
Online Radio
play_arrow
Audio Stories - A new movie experience
Online Radio
The Director-General of the Nigeria Centre for Disease Control (NCDC), Chikwe Ihekweazu, has assured Nigerians of the safety and efficacy of the Oxford/AstraZeneca COVID-19 vaccine.
Ihekweazu gave the assurance on Tuesday in Ebonyi state capital, Abakaliki, while handing over the newly-constructed molecular laboratory to the management of the Alex Ekwueme Federal University Teaching Hospital.
Spain, Germany, France are among the countries that have suspended the use of the vaccine over concerns relating to blood clotting.
The European Medicines Agency (EMA) is expected to release its findings on the vaccine on Thursday.
According to NAN, the NCDC boss said he is very confident that the doses administered in Nigeria are safe despite reports of some European countries suspending the administration of the vaccine.
“We are very confident of the vaccine we introduced in the country, and that it will become a game changer in the fight against COVID-19. I and other frontline staff have been vaccinated and I am still standing,” he was quoted to have said
“We should tell Nigerians that though faith is important in what we believe, the issue of vaccination is about science.
“When we believe that doctors, nurses, and other health personnel can provide us with healthcare based on understanding of science, we should then believe in the vaccine’s efficacy.”
Nigeria received 3.9 million doses of the Oxford/AstraZeneca vaccine on March 2.
Hollywood star, Viola Davis has once again made black women across the world proud with her latest achievement. The actress received her fourth Oscar nomination for her role in Ma […]
Post comments (0)